Management of Acute Kidney Injury and Acid-Base Balance in the Septic Patient

Clinics in Chest Medicine

Volumn 37, Issue 2, 2016, Pages 277-288

  Weyker, Paul D ^a   Pérez, Xosé L ^b   Liu, Kathleen D ^c  

^a Columbia University ^*  (United States)

^b HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acid base; Acute kidney injury; Acute renal failure; Biomarkers; Renal replacement therapy; Sepsis

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPHOTERICIN; BETA LACTAM ANTIBIOTIC; BICARBONATE; BUFFER; CHLORIDE; COLISTIN; DOPAMINE; HETASTARCH; HYPERTENSIVE FACTOR; IODINATED CONTRAST MEDIUM; METFORMIN; NORADRENALIN; TROMETAMOL; VANCOMYCIN; VASOPRESSIN; BIOLOGICAL MARKER;

ACID BASE BALANCE; ACUTE KIDNEY FAILURE; ACUTE KIDNEY TUBULE NECROSIS; CONTINUOUS RENAL REPLACEMENT THERAPY; EARLY GOAL DIRECTED THERAPY; EMERGENCY TREATMENT; HEMODIALYSIS; HUMAN; HYPERCHLOREMIA; HYPERKALEMIA; HYPERNATREMIA; HYPERVOLEMIA; HYPOCALCEMIA; HYPOGLYCEMIA; HYPONATREMIA; INTERSTITIAL NEPHRITIS; INTRAABDOMINAL HYPERTENSION; KIDNEY BLOOD FLOW; KIDNEY PERFUSION; LACTIC ACIDOSIS; MEAN ARTERIAL PRESSURE; METABOLIC ACIDOSIS; NEPHROTOXICITY; PH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENAL REPLACEMENT THERAPY; RESUSCITATION; REVIEW; RISK FACTOR; SEPSIS; SEPTIC SHOCK; SIDE EFFECT; SYSTEMATIC REVIEW (TOPIC); TREATMENT INDICATION; ACUTE KIDNEY INJURY; BLOOD; COMPLICATION; PHYSIOLOGY; PROCEDURES;

ACID-BASE EQUILIBRIUM; ACUTE KIDNEY INJURY; BIOMARKERS; HUMANS; RENAL REPLACEMENT THERAPY; SEPSIS;

EID: 84960969742     PISSN: 02725231     EISSN: 15578216     Source Type: Journal    
DOI: 10.1016/j.ccm.2016.01.012     Document Type: Review

References (106)

1. Bellomo R., Ronco C., Kellum J.A., et al. Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 2004, 8(4):R204-R212.
2. Mehta R.L., Kellum J.A., Shah S.V., et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007, 11(2):R31.
3. Kellum J.A., Lameire N., KDIGO AKI Guideline Work Group Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (Part 1). Crit Care 2013, 17(1):204.
4. Hoste E.A., Clermont G., Kersten A., et al. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: a cohort analysis. Crit Care 2006, 10(3):R73.
5. Uchino S., Kellum J.A., Bellomo R., et al. Acute renal failure in critically ill patients: a multinational, multicenter study. JAMA 2005, 294(7):813-818.
6. Lopes J.A., Jorge S., Resina C., et al. Prognostic utility of RIFLE for acute renal failure in patients with sepsis. Crit Care 2007, 11(2):408.
7. Thakar C.V., Christianson A., Freyberg R., et al. Incidence and outcomes of acute kidney injury in intensive care units: a Veterans Administration study. Crit Care Med 2009, 37(9):2552-2558.
8. Joannidis M., Metnitz B., Bauer P., et al. Acute kidney injury in critically ill patients classified by AKIN versus RIFLE using the SAPS 3 database. Intensive Care Med 2009, 35(10):1692-1702.
9. Piccinni P., Cruz D.N., Gramaticopolo S., et al. Prospective multicenter study on epidemiology of acute kidney injury in the ICU: a critical care nephrology Italian collaborative effort (NEFROINT). Minerva Anestesiol 2011, 77(11):1072-1083.
10. Kane-Gill S.L., Sileanu F.E., Murugan R., et al. Risk factors for acute kidney injury in older adults with critical illness: a retrospective cohort study. Am J Kidney Dis 2014, 65(6):860-869.
11. Hoste E.A., Bagshaw S.M., Bellomo R., et al. Epidemiology of acute kidney injury in critically ill patients: the multinational AKI-EPI study. Intensive Care Med 2015, 41(8):1411-1423.
12. Ali T., Khan I., Simpson W., et al. Incidence and outcomes in acute kidney injury: a comprehensive population-based study. J Am Soc Nephrol 2007, 18(4):1292-1298.
13. Bagshaw S.M., Uchino S., Bellomo R., et al. Septic acute kidney injury in critically ill patients: clinical characteristics and outcomes. Clin J Am Soc Nephrol 2007, 2(3):431-439.
14. Poukkanen M., Vaara S.T., Pettila V., et al. Acute kidney injury in patients with severe sepsis in Finnish intensive care units. Acta Anaesthesiol Scand 2013, 57(7):863-872.
15. Plataki M., Kashani K., Cabello-Garza J., et al. Predictors of acute kidney injury in septic shock patients: an observational cohort study. Clin J Am Soc Nephrol 2011, 6(7):1744-1751.
16. Rangel-Frausto M.S., Pittet D., Costigan M., et al. The natural history of the systemic inflammatory response syndrome (SIRS). A prospective study. JAMA 1995, 273(2):117-123.
17. Ahmed W., Memon A.I., Rehmani R., et al. Outcome of patients with acute kidney injury in severe sepsis and septic shock treated with early goal-directed therapy in an intensive care unit. Saudi J Kidney Dis Transpl 2014, 25(3):544-551.
18. Bagshaw S.M., George C., Bellomo R., et al. Early acute kidney injury and sepsis: a multicentre evaluation. Crit Care 2008, 12(2):R47.
19. Suh S.H., Kim C.S., Choi J.S., et al. Acute kidney injury in patients with sepsis and septic shock: risk factors and clinical outcomes. Yonsei Med J 2013, 54(4):965-972.
20. Lopes J.A., Jorge S., Resina C., et al. Acute renal failure in patients with sepsis. Crit Care 2007, 11(2):411.
21. Palevsky P.M., Zhang J.H., O'Connor T.Z., for the VA/NIH Acute Renal Failure Trials Network, et al. Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 2008, 359(1):7-20.
22. Bellomo R., Cass A., Cole L., for the RENAL Replacement Therapy Study Investigators, et al. Intensity of continuous renal-replacement therapy in critically ill patients. N Engl J Med 2009, 361(17):1627-1638.
23. Murugan R., Karajala-Subramanyam V., Lee M., et al. Acute kidney injury in non-severe pneumonia is associated with an increased immune response and lower survival. Kidney Int 2010, 77(6):527-535.
24. Takasu O., Gaut J.P., Watanabe E., et al. Mechanisms of cardiac and renal dysfunction in patients dying of sepsis. Am J Respir Crit Care Med 2013, 187(5):509-517.
25. Langenberg C., Bellomo R., May C., et al. Renal blood flow in sepsis. Crit Care 2005, 9(4):R363-R374.
26. Morrell E.D., Kellum J.A., Pastor-Soler N.M., et al. Septic acute kidney injury: molecular mechanisms and the importance of stratification and targeting therapy. Crit Care 2014, 18(5):501.
27. Langenberg C., Gobe G., Hood S., et al. Renal histopathology during experimental septic acute kidney injury and recovery. Crit Care Med 2014, 42(1):e58-e67.
28. Mariano F., Cantaluppi V., Stella M., et al. Circulating plasma factors induce tubular and glomerular alterations in septic burns patients. Crit Care 2008, 12(2):R42.
29. Gomez H., Ince C., De Backer D., et al. A unified theory of sepsis-induced acute kidney injury: inflammation, microcirculatory dysfunction, bioenergetics, and the tubular cell adaptation to injury. Shock 2014, 41(1):3-11.
30. Bellomo R., Wan L., Langenberg C., et al. Septic acute kidney injury: the glomerular arterioles. Contrib Nephrol 2011, 174:98-107.
31. Leaf D.E., Rajapurkar M., Lele S.S., et al. Plasma catalytic iron, AKI, and death among critically ill patients. Clin J Am Soc Nephrol 2014, 9(11):1849-1856.
32. Janz D.R., Bastarache J.A., Rice T.W., et al. Randomized, placebo-controlled trial of acetaminophen for the reduction of oxidative injury in severe sepsis: the acetaminophen for the reduction of oxidative injury in severe sepsis trial. Crit Care Med 2014, 43(3):534-541.
33. Prowle J.R., Chua H.R., Bagshaw S.M., et al. Clinical review: Volume of fluid resuscitation and the incidence of acute kidney injury - a systematic review. Crit Care 2012, 16(4):230.
34. Legrand M., Dupuis C., Simon C., et al. Association between systemic hemodynamics and septic acute kidney injury in critically ill patients: a retrospective observational study. Crit Care 2013, 17(6):R278.
35. Prowle J.R., Kirwan C.J., Bellomo R. Fluid management for the prevention and attenuation of acute kidney injury. Nat Rev Nephrol 2014, 10(1):37-47.
36. Investigators A., Group A.C.T., Peake S.L., et al. Goal-directed resuscitation for patients with early septic shock. N Engl J Med 2014, 371(16):1496-1506.
37. Pro C.I., Yealy D.M., Kellum J.A., et al. A randomized trial of protocol-based care for early septic shock. N Engl J Med 2014, 370(18):1683-1693.
38. Mouncey P.R., Osborn T.M., Power G.S., et al. Trial of early, goal-directed resuscitation for septic shock. N Engl J Med 2015, 372(14):1301-1311.
39. Kellum J.A., Mythen M.G., Shaw A.D. The 12th consensus conference of the Acute Dialysis Quality Initiative (ADQI XII). Br J Anaesth 2014, 113(5):729-731.
40. Hoste E.A., Maitland K., Brudney C.S., et al. Four phases of intravenous fluid therapy: a conceptual model. Br J Anaesth 2014, 113(5):740-747.
41. Grams M.E., Estrella M.M., Coresh J., et al. Fluid balance, diuretic use, and mortality in acute kidney injury. Clin J Am Soc Nephrol 2011, 6(5):966-973.
42. Asfar P., Meziani F., Hamel J.F., et al. High versus low blood-pressure target in patients with septic shock. N Engl J Med 2014, 370(17):1583-1593.
43. De Backer D., Biston P., Devriendt J., et al. Comparison of dopamine and norepinephrine in the treatment of shock. N Engl J Med 2010, 362(9):779-789.
44. *. Crit Care Med 2012, 40(3):725-730.
45. Vasu T.S., Cavallazzi R., Hirani A., et al. Norepinephrine or dopamine for septic shock: systematic review of randomized clinical trials. J Intensive Care Med 2012, 27(3):172-178.
46. Dellinger R.P., Levy M.M., Rhodes A., et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med 2013, 41(2):580-637.
47. Russell J.A. Bench-to-bedside review: vasopressin in the management of septic shock. Crit Care 2011, 15(4):226.
48. Holmes C.L., Patel B.M., Russell J.A., et al. Physiology of vasopressin relevant to management of septic shock. Chest 2001, 120(3):989-1002.
49. Tsuneyoshi I., Yamada H., Kakihana Y., et al. Hemodynamic and metabolic effects of low-dose vasopressin infusions in vasodilatory septic shock. Crit Care Med 2001, 29(3):487-493.
50. Patel B.M., Chittock D.R., Russell J.A., et al. Beneficial effects of short-term vasopressin infusion during severe septic shock. Anesthesiology 2002, 96(3):576-582.
51. Russell J.A., Walley K.R., Singer J., et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008, 358(9):877-887.
52. Chertow G.M., Sayegh M.H., Allgren R.L., et al. Is the administration of dopamine associated with adverse or favorable outcomes in acute renal failure? Auriculin Anaritide Acute Renal Failure Study Group. Am J Med 1996, 101(1):49-53.
53. Bellomo R., Chapman M., Finfer S., et al. Low-dose dopamine in patients with early renal dysfunction: a placebo-controlled randomised trial. Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. Lancet 2000, 356(9248):2139-2143.
54. Jones D., Bellomo R. Renal-dose dopamine: from hypothesis to paradigm to dogma to myth and, finally, superstition?. J Intensive Care Med 2005, 20(4):199-211.
55. Perner A., Haase N., Guttormsen A.B., et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med 2012, 367(2):124-134.
56. Myburgh J.A., Finfer S., Bellomo R., et al. Hydroxyethyl starch or saline for fluid resuscitation in intensive care. N Engl J Med 2012, 367(20):1901-1911.
57. Haase N., Perner A., Hennings L.I., et al. Hydroxyethyl starch 130/0.38-0.45 versus crystalloid or albumin in patients with sepsis: systematic review with meta-analysis and trial sequential analysis. BMJ 2013, 346:f839.
58. Zarychanski R., Abou-Setta A.M., Turgeon A.F., et al. Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation: a systematic review and meta-analysis. JAMA 2013, 309(7):678-688.
59. Yunos N.M., Bellomo R., Hegarty C., et al. Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults. JAMA 2012, 308(15):1566-1572.
60. *. Crit Care Med 2014, 42(7):1585-1591.
61. Yunos N.M., Bellomo R., Story D., et al. Bench-to-bedside review: chloride in critical illness. Crit Care 2010, 14(4):226.
62. Young P., Bailey M., Beasley R., et al. Effect of a buffered crystalloid solution vs saline on acute kidney injury among patients in the intensive care unit: the split randomized clinical trial. JAMA 2015, 314(16):1701-1710.
63. Shaw A.D., Bagshaw S.M., Goldstein S.L., et al. Major complications, mortality, and resource utilization after open abdominal surgery: 0.9% saline compared to Plasma-Lyte. Ann Surg 2012, 255(5):821-829.
64. Eftekhari P. Evaluation of acute kidney injury in the hospital setting. Prim Care 2014, 41(4):779-802.
65. Hazlewood K.A., Brouse S.D., Pitcher W.D., et al. Vancomycin-associated nephrotoxicity: grave concern or death by character assassination?. Am J Med 2010, 123(2):182.e1-182.e7.
66. Cano E.L., Haque N.Z., Welch V.L., et al. Incidence of nephrotoxicity and association with vancomycin use in intensive care unit patients with pneumonia: retrospective analysis of the IMPACT-HAP Database. Clin Ther 2012, 34(1):149-157.
67. Elyasi S., Khalili H., Dashti-Khavidaki S., et al. Vancomycin-induced nephrotoxicity: mechanism, incidence, risk factors and special populations. A literature review. Eur J Clin Pharmacol 2012, 68(9):1243-1255.
68. Meaney C.J., Hynicka L.M., Tsoukleris M.G. Vancomycin-associated nephrotoxicity in adult medicine patients: incidence, outcomes, and risk factors. Pharmacotherapy 2014, 34(7):653-661.
69. Weisbord S.D., Gallagher M., Kaufman J., et al. Prevention of contrast-induced AKI: a review of published trials and the design of the prevention of serious adverse events following angiography (PRESERVE) trial. Clin J Am Soc Nephrol 2013, 8(9):1618-1631.
70. Mueller C. Prevention of contrast-induced nephropathy with volume supplementation. Kidney Int Suppl 2006, (100):S16-S19.
71. Trivedi H.S., Moore H., Nasr S., et al. A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity. Nephron Clin Pract 2003, 93(1):C29-C34.
72. Kallen A.J., Jhung M.A., Cheng S., et al. Gadolinium-containing magnetic resonance imaging contrast and nephrogenic systemic fibrosis: a case-control study. Am J Kidney Dis 2008, 51(6):966-975.
73. Zou Z., Zhang H.L., Roditi G.H., et al. Nephrogenic systemic fibrosis: review of 370 biopsy-confirmed cases. JACC Cardiovasc Imaging 2011, 4(11):1206-1216.
74. Chien C.C., Wang H.Y., Wang J.J., et al. Risk of acute kidney injury after exposure to gadolinium-based contrast in patients with renal impairment. Ren Fail 2011, 33(8):758-764.
75. Murugan R., Weissfeld L., Yende S., et al. Association of statin use with risk and outcome of acute kidney injury in community-acquired pneumonia. Clin J Am Soc Nephrol 2012, 7(6):895-905.
76. Deshpande A., Pasupuleti V., Rothberg M.B. Statin therapy and mortality from sepsis: a meta-analysis of randomized trials. Am J Med 2015, 128(4):410-417.e1.
77. Palevsky P.M. Renal replacement therapy in acute kidney injury. Adv Chronic Kidney Dis 2013, 20(1):76-84.
78. Palevsky P.M., Baldwin I., Davenport A., et al. Renal replacement therapy and the kidney: minimizing the impact of renal replacement therapy on recovery of acute renal failure. Curr Opin Crit Care 2005, 11(6):548-554.
79. Maynar Moliner J., Honore P.M., Sanchez-Izquierdo Riera J.A., et al. Handling continuous renal replacement therapy-related adverse effects in intensive care unit patients: the daily trauma concept. Blood Purif 2012, 34(2):177-185.
80. Liu K.D., Himmelfarb J., Paganini E., et al. Timing of initiation of dialysis in critically ill patients with acute kidney injury. Clin J Am Soc Nephrol 2006, 1(5):915-919.
81. Karvellas C.J., Farhat M.R., Sajjad I., et al. A comparison of early versus late initiation of renal replacement therapy in critically ill patients with acute kidney injury: a systematic review and meta-analysis. Crit Care 2011, 15(1):R72.
82. Wald R., Adhikari N.K., Smith O.M., et al. Comparison of standard and accelerated initiation of renal replacement therapy in acute kidney injury. Kidney Int 2015, 88(4):897-904.
83. Lameire N., Kellum J.A., KDIGO AKI Guideline Work Group Contrast-induced acute kidney injury and renal support for acute kidney injury: a KDIGO summary (Part 2). Crit Care 2013, 17(1):205.
84. *. Crit Care Med 2014, 42(4):868-877.
85. Rewa O., Bagshaw S.M. Acute kidney injury-epidemiology, outcomes and economics. Nat Rev Nephrol 2014, 10(4):193-207.
86. Fieghen H.E., Friedrich J.O., Burns K.E., et al. The hemodynamic tolerability and feasibility of sustained low efficiency dialysis in the management of critically ill patients with acute kidney injury. BMC Nephrol 2010, 11:32.
87. Harris L.E., Reaves A.B., Krauss A.G., et al. Evaluation of antibiotic prescribing patterns in patients receiving sustained low-efficiency dialysis: opportunities for pharmacists. Int J Pharm Pract 2013, 21(1):55-61.
88. Mei J.P., Ali-Moghaddam A., Mueller B.A. Survey of pharmacists' antibiotic dosing recommendations for sustained low-efficiency dialysis. Int J Clin Pharm 2015, [Epub ahead of print].
89. Ronco C., Bellomo R., Homel P., et al. Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomized trial. Lancet 2000, 356:26-30.
90. Schiffl H., Lang S., Fischer R. Daily hemodialysis and the outcome of acute renal failure. N Engl J Med 2002, 346:305-310.
91. Roberts D.M., Roberts J.A., Roberts M.S., et al. Variability of antibiotic concentrations in critically ill patients receiving continuous renal replacement therapy: a multicentre pharmacokinetic study. Crit Care Med 2012, 40(5):1523-1528.
92. Seyler L., Cotton F., Taccone F.S., et al. Recommended beta-lactam regimens are inadequate in septic patients treated with continuous renal replacement therapy. Crit Care 2011, 15(3):R137.
93. Bauer S.R., Salem C., Connor M.J., et al. Pharmacokinetics and pharmacodynamics of piperacillin-tazobactam in 42 patients treated with concomitant CRRT. Clin J Am Soc Nephrol 2012, 7(3):452-457.
94. Fissell W.H. Antimicrobial dosing in acute renal replacement. Adv Chronic Kidney Dis 2013, 20(1):85-93.
95. Jamal J.A., Economou C.J., Lipman J., et al. Improving antibiotic dosing in special situations in the ICU: burns, renal replacement therapy and extracorporeal membrane oxygenation. Curr Opin Crit Care 2012, 18(5):460-471.
96. Bellomo R. Bench-to-bedside review: lactate and the kidney. Crit Care 2002, 6(4):322-326.
97. Forsythe S.M., Schmidt G.A. Sodium bicarbonate for the treatment of lactic acidosis. Chest 2000, 117(1):260-267.
98. Boyd J.H., Walley K.R. Is there a role for sodium bicarbonate in treating lactic acidosis from shock?. Curr Opin Crit Care 2008, 14(4):379-383.
99. Calello D.P., Liu K.D., Wiegand T.J., et al. Extracorporeal treatment for metformin poisoning: systematic review and recommendations from the extracorporeal treatments in poisoning workgroup. Crit Care Med 2015, 43(8):1716-1730.
100. Kraut J.A., Madias N.E. Lactic acidosis. N Engl J Med 2014, 371(24):2309-2319.
101. Hoste E.A., Colpaert K., Vanholder R.C., et al. Sodium bicarbonate versus THAM in ICU patients with mild metabolic acidosis. J Nephrol 2005, 18(3):303-307.
102. Doi K., Yuen P.S., Eisner C., et al. Reduced production of creatinine limits its use as marker of kidney injury in sepsis. J Am Soc Nephrol 2009, 20(6):1217-1221.
103. Solomon A.W., Kirwan C.J., Alexander N.D., et al. Urine output on an intensive care unit: case-control study. BMJ 2010, 341:c6761.
104. Delanaye P., Cavalier E., Morel J., et al. Detection of decreased glomerular filtration rate in intensive care units: serum cystatin C versus serum creatinine. BMC Nephrol 2014, 15:9.
105. Bihorac A., Chawla L.S., Shaw A.D., et al. Validation of cell-cycle arrest biomarkers for acute kidney injury using clinical adjudication. Am J Respir Crit Care Med 2014, 189(8):932-939.
106. Kashani K., Al-Khafaji A., Ardiles T., et al. Discovery and validation of cell cycle arrest biomarkers in human acute kidney injury. Crit Care 2013, 17(1):R25.